Nanomedicine News

RSS

Sevion Enters Agreement with Malvern to Establish New Biopharmaceutical Applications Laboratory

Sevion Therapeutics, Inc., a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, has entered into an agreement with Malvern Instruments establishing a new biopharmaceutical applications laboratory in the heart of San Diego’s biotechnology cluster.

31 Jul 2015

Novavax Reports Top-Line Data from Phase 2 Clinical Trial of Recombinant Quadrivalent Seasonal Influenza VLP Vaccine Candidate

Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced positive top-line data from a Phase 2 clinical trial of its recombinant quadrivalent seasonal influenza virus-like particle (VLP) vaccine candidate (Seasonal Influenza VLP).

From Novavax Inc. 31 Jul 2015

FDA Grants Orphan Drug Designation for Second NanoSmart Product Using Proprietary Drug Delivery Platform

NanoSmart Pharmaceuticals, Inc., a private pharmaceutical company developing nanoparticle drug delivery platforms, has received Orphan Drug Designation from the Food and Drug Administration (FDA) for a second drug product that uses NanoSmart's proprietary drug delivery platform.

31 Jul 2015

FDA Clears Ignyta's IND for RXDX-107 Alkyl Ester of Bendamustine Encapsulated in HSA to Form Nanoparticles

Ignyta, Inc., a precision oncology biotechnology company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug application (IND) for Ignyta’s new chemical entity RXDX-107, a next-generation alkyl ester of bendamustine encapsulated in human serum albumin (HSA) to form nanoparticles.

30 Jul 2015

Researchers Aim to Grow Nanoflowers Seeded from Metal Nanoparticles Producing Fractals that Mimic Neurons

Richard Taylor's vision of using artificial fractal-based implants to restore sight to the blind -- part of a far-reaching concept that won an innovation award this year from the White House -- is now covered under a broad U.S. patent.

29 Jul 2015

MonoSol Rx Initiates Phase 2a Study for Midaform® Insulin PharmFilm®, MSL- 001

MonoSol Rx, the developer of PharmFilm drug delivery technology, with its partner Midatech Pharma, announced today that it has initiated a Phase 2a study for Midaform® Insulin PharmFilm®, MSL- 001, with the dosing of its first patient.

28 Jul 2015

Matinas BioPharma Announces Presentation of Preclinical Data on Encochleated Atovaquone at IDWeek 2015

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective antifungal and anti-bacterial therapeutics for the treatment of serious and life-threatening infections, today announced that preclinical data on encochleated atovaquone (CATQ) will be presented at IDWeek 2015 Oct. 7-11 in San Diego.

28 Jul 2015

New License Enables Use of Innova’s Lightning-Link and InnovaCoat GOLD Technologies in Mologic’s Kits

Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, and Mologic, a specialist diagnostic development company and molecular reagent innovator, announced today the signing of a supply and licensing agreement for use of Innova’s Lightning-Link® and InnovaCoat® GOLD technologies as part of Mologic’s commercial assay development services and range of immunoassays.

28 Jul 2015

ACPHS to Host Symposium and Workshop on Latest Advances in Nanomedicine

The Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences (ACPHS) will host a Symposium and Workshop August 3-7 to explore the latest advances in the field of Nanomedicine. The event will take place in the Gozzo Student Center located on the ACPHS Campus.

24 Jul 2015

Researchers Create Artificial Version of Transcription Factor Using Gold Nanoparticles

Stem cells hold great potential for addressing a variety of conditions from spinal cord injuries to cancer, but they can be difficult to control. Scientists are now reporting in the journal ACS Nano a new way to mimic the body's natural approach to programming these cells.

23 Jul 2015

Nanomedicine News

Sevion Enters Agreement with Malvern to Establish New Biopharmaceutical Applications Laboratory

Novavax Reports Top-Line Data from Phase 2 Clinical Trial of Recombinant Quadrivalent Seasonal Influenza VLP Vaccine Candidate

FDA Grants Orphan Drug Designation for Second NanoSmart Product Using Proprietary Drug Delivery Platform

FDA Clears Ignyta's IND for RXDX-107 Alkyl Ester of Bendamustine Encapsulated in HSA to Form Nanoparticles

Researchers Aim to Grow Nanoflowers Seeded from Metal Nanoparticles Producing Fractals that Mimic Neurons

MonoSol Rx Initiates Phase 2a Study for Midaform® Insulin PharmFilm®, MSL- 001

Matinas BioPharma Announces Presentation of Preclinical Data on Encochleated Atovaquone at IDWeek 2015

New License Enables Use of Innova’s Lightning-Link and InnovaCoat GOLD Technologies in Mologic’s Kits

ACPHS to Host Symposium and Workshop on Latest Advances in Nanomedicine

Researchers Create Artificial Version of Transcription Factor Using Gold Nanoparticles

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting